Fig. 2From: Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approachKey lesion rather peripher located to the primary tumor. Disconcordance of (a) FDG PET/CT and (b) non-invasive Pentixafor PET/CT imaging in one patient suffering from esophageal cancer. The lesion demonstrates high CXCR4 expression; local response was able to be shown in re-staging PET/CT after radiochemotherapy. Arrow indicates the lesionBack to article page